12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-κB

被引:99
作者
Bolick, DT
Orr, AW
Whetzel, A
Srinivasan, S
Hatley, ME
Schwartz, MA
Hedrick, CC
机构
[1] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA
关键词
endothelium; 2/15-lipoxygenase; RhoA; ICAM-1;
D O I
10.1161/01.ATV.0000186181.19909.a6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-12/15-lipoxygenase (12/15-LO) activity leads to the production of the proinflammatory eicosanoids 12-S-hydroxyeicosatetraenoic acid (12SHETE) and 13-S-hydroxyoctadecadienoic acid. We have previously shown a 3.5-fold increase in endothelial intercellular adhesion molecule (ICAM)-1 expression in mice overexpressing the 12/15-LO gene. We examined whether 12/15-LO activity regulated endothelial ICAM-1 expression. Methods and Results-Freshly isolated aortic endothelial cells (EC) from 12/15-LO transgenic mice had significantly greater nuclear factor-kappa B (NF-kappa B) activation and ICAM mRNA expression compared with C57BL/6J control. 12/15-LO transgenic EC showed elevated RhoA activity, and inhibition of RhoA using either C3 toxin or the Rho-kinase inhibitor Y-27632 blocked NF-kappa B activation, ICAM-1 induction, and monocyte adhesion. Furthermore, we show that 12SHETE activates protein kinase C alpha, which forms a complex with active RhoA and is required for NF-kappa B-dependent ICAM expression in response to 12SHETE. Conclusions-The 12/15-LO pathway stimulates ICAM-1 expression through the RhoA/protein kinase C alpha-dependent activation of NF-kappa B. These findings identify a major signaling pathway in EC through which 12/15-LO contributes to vascular inflammation and atherosclerosis.
引用
收藏
页码:2301 / 2307
页数:7
相关论文
共 56 条
[11]   A major role for VCAM-1, but not ICAM-1, in early atherosclerosis [J].
Cybulsky, MI ;
Iiyama, K ;
Li, HM ;
Zhu, SN ;
Chen, M ;
Iiyama, M ;
Davis, V ;
Gutierrez-Ramos, JC ;
Connelly, PW ;
Milstone, DS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) :1255-1262
[12]   Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice [J].
Cyrus, T ;
Witztum, JL ;
Rader, DJ ;
Tangirala, R ;
Fazio, S ;
Linton, MF ;
Funk, CD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1597-1604
[13]  
Cyrus T, 2001, CIRCULATION, V103, P2277
[14]  
Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116
[15]   12/15-lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice [J].
George, J ;
Afek, A ;
Shaish, A ;
Levkovitz, H ;
Bloom, N ;
Cyrus, T ;
Zhao, L ;
Funk, CD ;
Sigal, E ;
Harats, D .
CIRCULATION, 2001, 104 (14) :1646-1650
[16]  
GERRITY RG, 1981, AM J PATHOL, V103, P191
[17]  
GILCHRIST A, 2002, SCI STKE, pL1
[18]   Multiple signaling pathways regulate NF-κB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells [J].
Goebeler, M ;
Gillitzer, R ;
Kilian, K ;
Utzel, K ;
Bröcker, EB ;
Rapp, UR ;
Ludwig, S .
BLOOD, 2001, 97 (01) :46-55
[19]   Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice [J].
Hatley, ME ;
Srinivasan, S ;
Reilly, KB ;
Bolick, DT ;
Hedrick, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :25369-25375
[20]  
Hedrick CC, 1999, ADV EXP MED BIOL, V469, P455